Nurse Practitioner, Family · San Francisco, CA
NPI
1689071433
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1001 Portrero Ave, Suite 3d
San Francisco, CA, 94110
Phone (415) 531-0461
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
805 prescriptions
Company payments, 2023
$72.25
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Catherine A Magee prescribed most often to Medicare patients was Vemlidy (Tenofovir Alafenamide), with 567 prescriptions and refills. In total Catherine A Magee wrote 805 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vemlidy Tenofovir Alafenamide | 567 | 611 | 75 | $899K |
| Entecavir Generic | 132 | 364 | 43 | $105K |
| Tenofovir Disoproxil Fumarate Generic | 35 | 73 | Under 11 | $23K |
| Ursodiol Generic | 26 | 71 | Under 11 | $4,848 |
| Epclusa Sofosbuvir/Velpatasvir | 13 | 13 | Under 11 | $317K |
Brand drugs: 601 claims; generic drugs: 204 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Catherine A Magee $72.25 ($72.25 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $72.25.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $72.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.